365 related articles for article (PubMed ID: 28638930)
1. [Different adipose tissue depots and metabolic syndrome in human].
Wang R; Li XN
Sheng Li Xue Bao; 2017 Jun; 69(3):357-365. PubMed ID: 28638930
[TBL] [Abstract][Full Text] [Related]
2. The sexual dimorphism of obesity.
Palmer BF; Clegg DJ
Mol Cell Endocrinol; 2015 Feb; 402():113-9. PubMed ID: 25578600
[TBL] [Abstract][Full Text] [Related]
3. Detrimental and protective fat: body fat distribution and its relation to metabolic disease.
Booth A; Magnuson A; Foster M
Horm Mol Biol Clin Investig; 2014 Jan; 17(1):13-27. PubMed ID: 25372727
[TBL] [Abstract][Full Text] [Related]
4. The regulation of adipose tissue distribution in humans.
Björntorp P
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery.
Dadson P; Ferrannini E; Landini L; Hannukainen JC; Kalliokoski KK; Vaittinen M; Honka H; Karlsson HK; Tuulari JJ; Soinio M; Salminen P; Parkkola R; Pihlajamäki J; Iozzo P; Nuutila P
Am J Physiol Endocrinol Metab; 2017 Aug; 313(2):E175-E182. PubMed ID: 28400411
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis.
Wajchenberg BL; Nery M; Cunha MR; Silva ME
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):145-50. PubMed ID: 19466206
[TBL] [Abstract][Full Text] [Related]
10. Adipose 'neighborhoods' collaborate to maintain metabolic health.
Fried SK
Curr Opin Genet Dev; 2023 Aug; 81():102079. PubMed ID: 37406429
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk of adipokines: a review.
Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin.
de Heredia FP; Larque E; Portillo MP; Canteras M; Zamora S; Garaulet M
Nutrition; 2008 Oct; 24(10):1013-22. PubMed ID: 18562171
[TBL] [Abstract][Full Text] [Related]
13. Under the Surface of Subcutaneous Adipose Tissue Biology.
Pandžić Jakšić V; Grizelj D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):250-260. PubMed ID: 28128075
[TBL] [Abstract][Full Text] [Related]
14. Diets and morbid tissues--history counts, present counts.
Henkin Y; Kovsan J; Gepner Y; Shai I
Br J Nutr; 2015 Apr; 113 Suppl 2():S11-8. PubMed ID: 26148913
[TBL] [Abstract][Full Text] [Related]
15. Ectopic fat and cardiometabolic and vascular risk.
Lim S; Meigs JB
Int J Cardiol; 2013 Nov; 169(3):166-76. PubMed ID: 24063931
[TBL] [Abstract][Full Text] [Related]
16. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
Hill JH; Solt C; Foster MT
Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
[TBL] [Abstract][Full Text] [Related]
17. Relationship between visceral obesity and plasma fibrinogen in obese children.
Hafez M; El-Masry S; Musa N; Fathy M; Hassan M; Hassan N; El Husseiny M; Tareef M
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):289-96. PubMed ID: 26565545
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
Hajer GR; van Haeften TW; Visseren FL
Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Milutinović DV; Nikolić M; Veličković N; Djordjevic A; Bursać B; Nestorov J; Teofilović A; Antić IB; Macut JB; Zidane AS; Matić G; Macut D
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):522-529. PubMed ID: 28407665
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Katsiki N; Athyros VG; Mikhailidis DP
Curr Vasc Pharmacol; 2016; 14(5):432-441. PubMed ID: 27456108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]